Stack

Ipamorelin

Peptide reference entry

What it is: Growth hormone secretagogue peptide
What it does: Stimulates growth hormone release with relative receptor selectivity
Status: Experimental
Evidence: Low. Mostly preclinical and small human studies.
Uses: GH-axis support research; recovery

Caution. Evidence base remains limited.

Summary

Ipamorelin is a ghrelin-receptor agonist that selectively stimulates GH release with less effect on cortisol and prolactin than some secretagogues. It has been studied in small human trials for postoperative recovery and GI motility, but not broadly for body composition. Overall evidence is still early-stage and not definitive for common off-label uses.

Checked Jul 15, 2026.

Keep a record of Ipamorelin in Stack

Stack logs each dose you take, tracks what is left in the vial or bottle and shows how you kept to your plan. It records what you choose and does not recommend anything. Everything stays on your phone, with no account.

Get Stack on Google Play Peptide reconstitution calculator

More peptides

NAD+Experimental · moderate evidence SemaxExperimental · low evidence SelankExperimental · low evidence MOTS-CExperimental · low evidence CagrilintideInvestigational · moderate evidence

This entry summarises published information in plain language. It is not medical advice, a dosing recommendation or a substitute for a qualified healthcare professional. Many peptides are not approved for human use, and legal status varies by country. Check anything you rely on against primary sources.